Ibuprofen does not improve bronchopulmonary dysplasia outcomes

1. This randomized controlled trial showed no evidence that ibuprofen treatment for bronchopulmonary dysplasia reduced premature infant mortality. 2. This study is consistent with other studies examining the role of ibuprofen as a treatment method for patent ductus arteriosus (PDA), showing no effect on mortality rates. Evidence Rating Level: 1 (Excellent) Study Rundown: Neonatal medicine […]

The post Ibuprofen does not improve bronchopulmonary dysplasia outcomes first appeared on 2 Minute Medicine.